| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.27 | 0.1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |